Edgen Stock·Nov 25 2025, 21:34返回
返回
諾和諾德股價因下一代肥胖症藥物Amycretin的積極數據而飆升
Edgen Stock·Nov 25 2025, 21:34
[1] 諾和諾德藥物幫助患者減肥，降低血糖... (https://www.wsj.com/health/pharma/novo-nordis ...)[2] 諾和諾德稱新型糖尿病注射劑促使體重減輕14.5% - 彭博社 (https://www.bloomberg.com/news/articles/2025- ...)[3] 諾和諾德將下一代藥物amycretin推向晚期糖尿病... (https://www.cnbc.com/2025/11/25/novos-next-ge ...)